propranolol has been researched along with glucagon-like peptide 1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiyama, K; Hoshino, T; Ikeda, T; Mashiba, H; Ochi, H; Ohtani, I; Takeuchi, T; Tanaka, Y | 1 |
| Dige-Petersen, H; Hilsted, J; Holst, JJ; Hvidberg, A; Toft-Nielsen, M | 1 |
| Giralt, M; Vergara, P | 1 |
| Endo, M; Inoue, S; Osaka, T; Yamakawa, M | 1 |
1 trial(s) available for propranolol and glucagon-like peptide 1
| Article | Year |
|---|---|
No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Drug Interactions; Epinephrine; Fasting; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Male; Norepinephrine; Peptide Fragments; Propranolol; Protein Precursors; Reference Values | 1996 |
3 other study(ies) available for propranolol and glucagon-like peptide 1
| Article | Year |
|---|---|
Possible role of the adrenergic mechanism in gastric inhibitory polypeptide- and glucagon-like peptide-1 (7-36) amide-induced insulin release in the rat.
Topics: Animals; Blood Glucose; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Insulin; Insulin Secretion; Male; Peptide Fragments; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 1993 |
Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat.
Topics: Adrenergic alpha-Antagonists; Animals; Duodenum; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Ileum; Jejunum; Male; Ovalbumin; Peptide Fragments; Peptones; Phentolamine; Propranolol; Protein Hydrolysates; Protein Precursors; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Receptors, Glucagon | 1999 |
Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system.
Topics: Adrenal Glands; Adrenalectomy; Animals; Area Postrema; Body Temperature; Brain Stem; Diabetes Mellitus, Experimental; Energy Metabolism; Ganglionectomy; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Heart Rate; Hexamethonium; Injections, Intravenous; Injections, Intraventricular; Male; Oxygen Consumption; Propranolol; Prosencephalon; Pulmonary Gas Exchange; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Sympathetic Nervous System; Vagotomy | 2005 |